Tech Company Financing Transactions

Svelte Medical Systems Funding Round

Svelte Medical Systems, operating out of New Providence, scored $22 million from CNF Investments, New Science Ventures and private investors.

Transaction Overview

Company Name
Svelte Medical Systems
Announced On
10/31/2013
Transaction Type
Venture Equity
Amount
$22,000,000
Round
Undisclosed
Investors

CNF Investments (Lead Investor)

New Science Ventures (Lead Investor) (Somu Subramaniam)

Proceeds Purpose
Proceeds from this round of financing will be used to complete the DIRECT II study, prepare for commercialization of the Svelte drug-eluting coronary stent Integrated Delivery System (IDS) and Rapid-Exchange (RX) platforms in Europe and expand overall operational infrastructure.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
675 Central Ave.
New Providence, NJ 07974
USA
Phone
(908) 264-2194
Website
www.sveltemedical.com
Email Address
[email protected]
Overview
Svelte Medical Systems, Inc. (Svelte) is a privately held company focused on delivering novel products in the $5 billion coronary stent market. Svelte has a mission to address key clinical issues in the stent market by improving stent deliverability, reducing cost and dramatically improving the safety of the device compared to currently market products.
Profile
Svelte Medical Systems LinkedIn Company Profile
Social Media
Svelte Medical Systems Company Twitter Account
Company News
Svelte Medical Systems News
Facebook
Svelte Medical Systems on Facebook
YouTube
Svelte Medical Systems on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Jack Darby
  Jack Darby LinkedIn Profile  Jack Darby Twitter Account  Jack Darby News  Jack Darby on Facebook
VP - Operations
Keith Roberts
  Keith Roberts LinkedIn Profile  Keith Roberts Twitter Account  Keith Roberts News  Keith Roberts on Facebook
VP - R & D
Diana Williamson
  Diana Williamson LinkedIn Profile  Diana Williamson Twitter Account  Diana Williamson News  Diana Williamson on Facebook
VP - Regulatory Affairs
Mark Kielek
  Mark Kielek LinkedIn Profile  Mark Kielek Twitter Account  Mark Kielek News  Mark Kielek on Facebook
VP - Sales
Richard Spencer
  Richard Spencer LinkedIn Profile  Richard Spencer Twitter Account  Richard Spencer News  Richard Spencer on Facebook

 

 

Browse more venture capital transactions:

Prev: 10/31/2013: AroundWire venture capital transaction
Next: 10/31/2013: Halt Medical venture capital transaction

 

Share this article

 

About Our VC Transactions Data

Our team works diligently to report on funding rounds that are announced publicly. All VC database entries on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.